AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
46 hedge funds and large institutions have $4.55M invested in Accelerate Diagnostics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
54% less capital invested
Capital invested by funds: $9.79M → $4.55M (-$5.24M)
Holders
46
Holding in Top 10
–
Calls
$20K
Puts
$2K
Top Buyers
1 | +$1.83M | |
2 | +$133K | |
3 | +$114K | |
4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$99K |
5 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
+$79.7K |
Top Sellers
1 | -$270K | |
2 | -$124K | |
3 | -$70.6K | |
4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$68.8K |
5 |
Citadel Advisors
Miami,
Florida
|
-$60.5K |